Variability in forgoing life-sustaining treatment practices in critically Ill patients with hospital-acquired bloodstream infections: a secondary analysis of the EUROBACT-2 international cohort

Hannah Wozniak,Alexis Tabah,Jan J. De Waele,Jean-François Timsit,Niccolò Buetti,EUROBACT-2 Study Group,the European Society of Intensive Care Medicine (ESICM),the European Society of Clinical Microbiology,the Infectious Diseases (ESCMID) Study Group for Infections in Critically Ill Patients (ESGCIP),the OUTCOMEREA Network
DOI: https://doi.org/10.1186/s13054-024-05072-1
IF: 15.1
2024-09-03
Critical Care
Abstract:The decision to forgo life-sustaining treatment in intensive care units (ICUs) is influenced by ethical, cultural, and medical factors. This study focuses on a population of patients with hospital-acquired bloodstream infections (HABSI) to investigate the association between patient, pathogen, center and country-level factors and these decisions.
critical care medicine
What problem does this paper attempt to address?